New combo tackles Hard-to-Treat breast cancer
NCT ID NCT04360941
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This early-stage study tests two drugs, palbociclib and avelumab, together for people with a specific type of advanced breast cancer (AR+ triple negative). The main goals are to find the safest doses and see if the combination can shrink tumors. About 45 participants will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERΑ+ BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust
RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Barts Cancer Institute
RECRUITINGLondon, EC1M 6BQ, United Kingdom
-
Beatson West of Scotland Cancer Centre
RECRUITINGGlasgow, G12 0YN, United Kingdom
-
Hope Clinical Trials Cancer Centre
RECRUITINGLeicester, LE1 5WW, United Kingdom
-
Nottingham University Hospital
ACTIVE_NOT_RECRUITINGNottingham, NG5 1PB, United Kingdom
-
Royal Marsden NHS Foundation Trust
RECRUITINGLondon, SW3 6JJ, United Kingdom
-
The Christie NHS Foundation Trust
RECRUITINGManchester, Greater Manchester, M20 4BX, United Kingdom
-
University College London Hospitals NHS Foundation Trust
RECRUITINGLondon, W1T 7HA, United Kingdom
-
Weston Park Hospital
RECRUITINGSheffield, S10 2SJ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a High-Fiber diet shield the gut during breast cancer therapy?
- Can a triple drug combo shrink HER2-Positive breast tumors before surgery?
- Can a Two-Drug attack shrink Hard-to-Treat breast cancer?
- Can an extra radiation dose keep HER2+ breast cancer at bay?
- Can mapping tumor DNA unlock personalized breast cancer care?
- Can a drug cocktail cure metastatic breast cancer? a trial aims to find out